HER2 overexpression, which is defined as an abnormal increase in the number of HER2 receptors on the surface of cancer cells, has been observed in a subset of head and neck squamous cell carcinomas, as well as in other types of cancer, such as breast cancer. This evidence concerns the gene ERBB2 and head and neck squamous cell carcinoma.